Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 800-803, 2003; 10.1373/49.5.800
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, W.
Right arrow Articles by Chong, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, W.
Right arrow Articles by Chong, S. S.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2003;49:800-803.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Multiple Minisequencing Screen for Seven Southeast Asian Nondeletional {alpha}-Thalassemia Mutations

Wen Wang1, Edmond S.K. Ma5, Amy Y.Y. Chan5, David H.K. Chui6 and Samuel S. Chong1,2,3,4,a

Departments of
1 Pediatrics and
2 Obstetrics & Gynecology, National University of Singapore 119074, Singapore
3 The Children’s Medical Institute and Molecular Diagnosis Center, Department of Laboratory Medicine, National University Hospital, Singapore 119074, Singapore

4 Departments of Pediatrics and Gynecology & Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287

5 Department of Pathology, The University of Hong Kong and Queen Mary Hospital, Hong Kong, People’s Republic of China

6 Departments of Medicine and Pathology, Boston University School of Medicine, Boston, MA 02118

aaddress correspondence to this author at: Department of Pediatrics, National University of Singapore, Level 4, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore; fax 65-6779-7486, e-mail paecs@nus.edu.sg

The first 300 words of the full text of this article appear below.

{alpha}-Thalassemia is the most common globin disorder in the world, and the severe forms are especially prevalent among Southeast Asians. It is a disorder of absent or reduced production of {alpha}-globin chains resulting from mutations in the {alpha}-globin gene cluster on chromosome 16p13.3. Most {alpha}-thalassemia mutations involve deletions of one (-{alpha}) or both (- -) {alpha}-globin genes, whereas point mutations within the {alpha}-globin genes ({alpha}T{alpha} or {alpha}{alpha}T) are much less frequent. Nonetheless, the number of point mutations that have been described has been steadily increasing, with >40 identified to date (1)(2).

The importance of nondeletional {alpha}-thalassemia mutations is underscored by the observation that patients with nondeletional hemoglobin (Hb) H disease ({alpha}T{alpha}/- -) are generally more severely affected and more likely to require transfusions compared with deletional Hb H disease patients (-{alpha}/- -) (3). There have also been a few reports of Hb H disease caused by homozygosity or compound heterozygosity of nondeletional mutations involving the {alpha}2-globin gene ({alpha}T{alpha}/{alpha}T{alpha}) (1)(3). Additionally, nondeletional Hb H disease involving the {alpha}2 codon 30 or codon 59 mutation can cause the fatal Hb H hydrops fetalis syndrome, especially if associated with large {zeta}-{alpha}-globin gene deletions (4). In certain regions of Southeast Asia, nondeletional Hb H disease can account for as many as 50% of all Hb H disease patients (3).

Several specific and reliable molecular tests have previously been developed to diagnose and screen the most common deletional (5)(6) and nondeletional (7)(8) {alpha}-thalassemia mutations. We now describe a multiplex minisequencing assay to detect seven Southeast Asian nondeletional mutations: Hb Constant Spring ({alpha}2 codon 142 TAA->CAA), Hb Paksé ({alpha}2 codon 142 TAA->TAT), Hb Quong . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. Y.-Y. Chan, H.-Y. Luo, W. Wang, D. H.K. Chui, E. S.-K. Ma, L.-C. Chan, and S. S. Chong
Diagnostic Pitfall in PCR-Based {alpha}-Thalassemia Genotyping Resulting from a (G->C) Polymorphism at Nucleotide 71 3' to the {alpha}2-Globin Gene Termination Codon.
Clin. Chem., March 1, 2006; 52(3): 536 - 537.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.